Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 08 Sept 2026 for Sarepta Therapeutics, Inc., €474k. Read the official filing
Filing timeline
BuySaleIan Michael Estepan
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ian Michael Estepan: trading record in brief
Ian Michael Estepan is a declared insider of Sarepta Therapeutics, Inc. (finance chief), with filings sourced from SEC (Form 4). Over a trading history stretching from 8 September 2021 to 4 September 2026, the count stands at 24 filings.
No open-market purchase appears, only 2 sales worth €992k. The rest of the record consists of 15 share grants and 6 option exercises.
On 8 September 2026 came the latest disclosure, a share grant for €474k in Sarepta Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ian Michael Estepan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
24,799 shares@ US$22.22Common StockSEC:0001193125-26-385544:0
1,097 shares@ US$17.030.7% of flowCommon StockSEC:0001193125-26-106710:0
1,036 shares@ US$16.950.7% of flowCommon StockSEC:0001193125-26-102701:0
8,125 sharesCommon StockSEC:0001193125-26-089432:0
2,069 shares@ US$13.711.1% of flowCommon StockSEC:0001193125-26-084265:0
13,187 shares@ US$22.3111.4% of flowCommon StockSEC:0001193125-25-325383:0
93,875 shares0Common StockSEC:0001193125-25-197423:0
5,500 sharesCommon StockSEC:0000950170-25-037519:0
17,500 sharesCommon StockSEC:0000950170-25-036695:0
1,370 shares@ US$101.346.5% of flowCommon StockSEC:0000950170-25-035003:0
557 shares@ US$103.772.7% of flowCommon StockSEC:0000950170-25-032760:0
14,267 shares@ US$12.008.0% of flowCommon StockSEC:0000950170-25-011959:0
250 shares0Common StockSEC:0000950170-24-141250:0
5,985 shares@ US$137.3636.1% of flowCommon StockSEC:0000950170-24-103070:0
6,250 sharesCommon StockSEC:0000950170-24-077519:0
526 shares@ US$120.492.8% of flowCommon StockSEC:0000950170-24-029529:0
1,389 shares@ US$125.327.8% of flowCommon StockSEC:0000950170-24-027498:0
365 shares@ US$126.192.1% of flowCommon StockSEC:0000950170-24-026605:0
744 shares@ US$153.195.3% of flowCommon StockSEC:0001209191-23-018020:0
1,370 shares@ US$157.219.9% of flowCommon StockSEC:0001209191-23-017408:0
378 shares@ US$147.572.6% of flowCommon StockSEC:0001209191-23-016055:0
1,308 shares@ US$79.204.2% of flowCommon StockSEC:0001209191-22-017347:0
376 shares@ US$75.051.1% of flowCommon StockSEC:0001209191-22-014408:0
1,623 shares@ US$78.294.8% of flowCommon StockSEC:0001209191-21-055383:0
24 of 24 declarations
